Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Hey! Dildos Sale in our Dildos Store!
Popular Articles

St. Petersburg Times Examines Work Of Paul Farmer, Potential Candidate For USAID, State Department Position
The St. Petersburg Times examines the work of Paul Farmer - "the Harvard-educated doctor who, starting in Haiti, built a multinational organization on the radical idea that poor patients deserve the same care as rich ones" and is reportedly being considered for a high-level job with USAID or the State Department. The newspaper reports that though it"s "not a sure thing, even his candidacy indicates how far the international aid establishment has come around to Farmer"s way of thinking, health care experts say."
drugs without prescription
Clear Innova Launches Innovative Radiology Information System
Clear Innova announced the launch of a next-generation radiology information system (RIS) that will serve as an efficient, cost-effective practice management solution for imaging centers and hospital radiology departments.
News of the day
NICE Announces Review Of Its Skin Cancer Guidance
The National Institute for Health and Clinical Excellence (NICE) has announced that it will convene a guidance development group to formally review the recommendations relating to the diagnosis and removal of "low risk" basal cell carcinomas (BCCs) in primary care in its guidance Improving Outcomes in Cancer for people with skin tumours including melanoma (2003).
Nutrition

SLU Explores Best Ways To Use Standard TB Vaccine

In a study funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, Saint Louis University"s Center for Vaccine Development is investigating whether the standard vaccine used in foreign countries against tuberculosis offers better protection as a shot, drink or combination of both. "The fight against tuberculosis is important because a third of the world is thought to be infected and there are significant problems with drug-resistant TB organisms," said Daniel Hoft, M.D., Ph.D., principal investigator and director of the division of immunobiology at Saint Louis University School of Medicine. The "standard" tuberculosis vaccine, bacillus Calmette-Guçİrin (BCG), is given to infants in foreign countries, and is not currently recommended for use in the U.S. "Experts believe it provides some protection against TB disease, particularly in children where severe manifestations of TB are averted," Hoft said. "However, despite widespread use of BCG, TB remains a major cause of death worldwide. The main purpose of this study is to find out if BCG can be used in a more effective way. "We hope to learn whether a BCG vaccine drink or a combination of a drink and an injection could increase immune responses against tuberculosis lung infection and affect the progression of the disease as it spreads throughout the body." The study also will look at whether it is better to give one or two doses of the BCG vaccine. A total of 70 healthy volunteers who are 18 to 40 years old are needed for the research. The study will last about two years and requires up to 21 scheduled visits. Each visit takes between 30 minutes and three hours, depending upon the procedures being performed. Study participants will be compensated for their time and travel after each completed visit. Tuberculosis is a deadly disease that strikes developing nations hardest. Each year, nearly 8 million new cases of TB develop, and 2 million persons die from the infectious disease. Saint Louis University Medical Center


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

İ Copyright 2009